13.00
0.08%
-0.010
After Hours:
12.99
-0.010
-0.08%
Paragon 28 Inc Stock (FNA) Latest News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AZPN, LRFC, ALVR on Behalf of Shareholders - Marketscreener.com
Zimmer touts ASC opportunity with Paragon 28 purchase - MedTech Dive
Grabar Law Office is Investigating Claims on Behalf of - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Zimmer Biomet Earnings Surge Past $2B Mark as Major Foot & Ankle Market Entry Looms - StockTitan
Zimmer Biomet to buy Paragon 28 for $1.1 billion - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AXL, TGI, AVAV on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Stockholders to Connect - Markets Insider
Zimmer Biomet to buy surgical device company Paragon 28 for $1.1B - MSN
Paragon 28's (FNA) "Equal Weight" Rating Reaffirmed at Stephens - MarketBeat
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates NARI, FNA, AZPN, TURN on Behalf of Shareholders - Marketscreener.com
Zimmer Biomet to acquire Paragon 28 in $1.2 billion deal - DOTmed
Strength Seen in Paragon 28, Inc. (FNA): Can Its 8.3% Jump Turn into More Strength? - MSN
Paragon 28 stock rating cut to Equal Weight by Stephens - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Zimmer Biomet agrees to acquire Paragon 28 for $1.2bn - MSN
Mvm Partners, Llc Sells 27,142 Shares of Paragon 28, Inc. (NYSE:FNA) Stock - MarketBeat
Paragon 28's (FNA) Hold Rating Reaffirmed at Canaccord Genuity Group - MarketBeat
Needham & Company LLC Reiterates "Hold" Rating for Paragon 28 (NYSE:FNA) - MarketBeat
Paragon 28 (NYSE:FNA) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Zimmer Biomet's rating and oultook affirmed at Moody's as Paragon 28 deal enhances growth and diversifies business - MSN
Zimmer Biomet to acquire Paragon 28 - Today's Medical Developments
Paragon 28 (NYSE:FNA) Cut to Market Perform at William Blair - MarketBeat
Paragon 28, Inc. (NYSE:FNA) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Inspire Investing LLC Decreases Stake in Paragon 28, Inc. (NYSE:FNA) - MarketBeat
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc. -January 31, 2025 at 04:26 pm EST - Marketscreener.com
Zimmer Biomet acquires Paragon 28 at $13/share - MSN
Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Canaccord Genuity Downgrades Paragon 28 (FNA) - MSN
Latham & Watkins Advises on Zimmer Biomet’s Acquisition of Paragon 28 - Legal Desire News Network
Assessing Paragon 28: Insights From 5 Financial Analysts - Benzinga
Paragon 28 (NYSE:FNA) Shares Gap UpShould You Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Investors to Reach Out - Markets Insider
Paragon 28 sees $1.32 million stock sale by MVM Partners - Investing.com Australia
Needham Downgrades Paragon 28 (FNA) - MSN
Paragon 28 stock rating downgraded to Hold at Needham - MSN
MVM Partners, LLC Adjusts Stake in Paragon 28 Inc - GuruFocus.com
First Light Asset Management, LLC Acquires Additional Shares in Paragon 28 Inc - GuruFocus.com
PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc.FNA - Business Wire
Items Tagged with 'foot & ankle' - BioWorld Online
Items Tagged with 'Paragon 28 Inc.' - BioWorld Online
Zimmer Biomet buying Paragon 28 for $1.1B to bolster F&A offerings - BioWorld Online
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):